TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

133.81

-8.12 (-5.72%)

At close: Jan 21, 2026, 4:00 PM EST

135.28

+1.47 (1.10%)

Pre-market: Jan 22, 2026, 4:11 AM EST

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
United States Lung Revenue	14.60M	15.76M	Log In	Log In	Log In	Upgrade
United States Heart Revenue	110.58M	96.66M	Log In	Log In	Log In	Upgrade
United States Liver Revenue	421.29M	309.46M	Log In	Log In	Log In	Upgrade
United States OCS Transplant Revenue	546.46M	421.88M	Log In	Log In	Log In	Upgrade
All Other Countries Lung Revenue	1.52M	1.93M	Log In	Log In	Log In	Upgrade
All Other Countries Heart Revenue	13.63M	13.20M	Log In	Log In	Log In	Upgrade
All Other Countries Liver Revenue	600.00K	158.00K	Log In	Log In	Log In	Upgrade
All Other Countries OCS Transplant Revenue	15.75M	15.28M	Log In	Log In	Log In	Upgrade
Total OCS Transplant Revenue	562.95M	437.16M	Log In	Log In	Log In	Upgrade
Other Service Revenue	-	4.38M	Log In	Log In	Log In	Upgrade
Revenue (Total)	566.35M	441.54M	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Net Product Revenue	346.96M	273.87M	Log In	Log In	Log In	Upgrade
Service Revenue	219.40M	167.67M	Log In	Log In	Log In	Upgrade
Revenue (Total)	566.35M	441.54M	Log In	Log In	Log In	Upgrade

Updated Oct 29, 2025. Data Source: Fiscal.ai.